Dexmedetomidine Infusion in Either Total Intravenous Anesthesia or Inhalational Anesthesia to Improve Surgical Field Visibility in Endoscopic Sinus Surgery

Menoufia University

Status and phase: Completed; Phase 4

Conditions: Rhinosinusitis

Treatments: Procedure: functional endoscopic sinus surgery; Drug: Dexmedetomidine

Study type: Interventional

Funder types: Other

Identifiers

NCT06866145

3/2024 ANE T8

Details and patient eligibility

About

Dexmedetomidine Infusion in either Total Intravenous Anesthesia or Inhalational Anesthesia to Improve Surgical Field Visibility in Endoscopic Sinus Surgery

Full description

the study was prospective randomized single blinded study

Enrollment: 50 patients

Sex: All

Ages: 18 to 50 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• American Society of Anesthesiologists (ASA) class I and II patients undergoing endoscopic sinus surgery in the age group from 18-50 years.

Exclusion criteria

• History of allergy to medications used in the study, refusal of patients to participate, hepatic or renal dysfunction, chronic pain condition, psychological and neurological disorders

Trial design

Primary purpose: Other

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

50 participants in 2 patient groups

TIVA group

Other group

Description:

patients receives total intravenous anesthesia

Treatment:

Drug: Dexmedetomidine

Procedure: functional endoscopic sinus surgery

inhalational group

Other group

Description:

patients receives inhalational anesthesia

Treatment:

Drug: Dexmedetomidine

Procedure: functional endoscopic sinus surgery